lifestyle.californiaconsumerbanking.com

Author: AbbVie Inc.

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

March 19, 2026
AbbVie Declares Quarterly Dividend

March 11, 2026
AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships

January 29, 2026
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

January 20, 2026
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

January 20, 2026
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans

January 12, 2026
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors

January 12, 2026
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

January 12, 2026
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

January 7, 2026
AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026